Nurofen feels pain in Australia over misleading claimsdrug giant Reckitt Benckiser was Monday ordered to pull some of its popular Nurofen painkiller brands off shelves in Australia after a court ruled they made misleading claims. Australia's consumer watchdog took court action in March, disputing Nurofen packaging that products in its Nurofen Specific Pain range were formulated to treat different types of pain, when the active ingredient was identical. The Federal Court ruled the British-based multinational engaged in misleading conduct with the main ingredient, 342 milligrams of ibuprofen lysine, the same in all the products with none any better at treating one type of pain than others.
Excerpt from:
Nurofen to be pulled in Australia over misleading claims
